Appl Immunohistochem Mol Morphol Journal
@AimmJournal
Followers
712
Following
86
Media
86
Statuses
292
Official Journal of @ISIMMweb - EIC: Paul Swanson Social Media Editor @katcollmd #AIMM Jc
#IHCpath
Joined July 2020
🚀 Join us for the launch of our Journal Club Webinar Series!.📚 Articles #openaccess starting July 28 .👨🏻💻 Don't miss this opportunity to explore new research with us! #AIMMjc . Register 👉🏻 🔗 🔗
0
8
33
RT @IHC_guy: Very special Announcement!. My beloved @AimmJournal is currently accepting applications for Editor-in-Chief. Paragon of IHC,….
0
18
0
RT @SethiRenalPath: A very happy and proud moment for me. Our son Amit started medical school at the University of Minnesota Medical School….
0
10
0
Comparison of Gastric Signet Ring Cell Carcinoma and Adenocarcinoma From Clinicopathologic Characteristics and Protein Expressions
journals.lww.com
, 2.3% for PMS2, 0.5% for MSH2, with PMS2 deficiencies more prevalent in old patients and only one MSH2 deletions observed in cardia-involved cases. E-cadherin loss was 13.5%, predominantly in males...
0
0
0
Just published! Check out the latest article!. 🔬 PD-L1 expression in breast carcinoma is more commonly expressed in TILs than in tumor cells.⚠️ Linked to poor prognostic factors.📉 No significant correlation between PD-L1 expression and disease-free survival.
Immunohistochemical Study on Programmed Death Ligand 1 (PD-L1) in Breast Carcinoma and Its Correlation With the Clinicopathological Parameters.
0
0
1
Just published! Check out the latest article by @d_e_n_i__z . 🧬 STAT6 is a diagnostic marker for Hodgkin lymphoma.🔍 Expression varies across HL subtypes.❌ STAT6-negative cases may indicate nodular lymphocyte-predominant HL.💊 STAT6 expression may guide therapy decisions.
STAT6 Can Be Used in the Diagnosis of Hodgkin Lymphoma; There Are Differences in Expression Among Subtypes
0
1
3
Investigating Biomarkers in Primary Tumors and Lymph Node Metastases in Tongue Squamous Cell Carcinoma: An Immunohistochemical Perspective
journals.lww.com
tases. A total of 60 TSCC biopsy samples, 20 primary metastatic, 20 lymph node metastatic, and 20 nonmetastatic, were immunohistochemically stained to analyze MCM2, CD44, and E-cadherin expression....
0
1
1
Distinct levels of DDIT3 Amplification in Dedifferentiated Liposarcoma Developing After DDIT3 Rearrangement in Myxoid Liposarcoma
journals.lww.com
diagnostic tool for accurate diagnosis. While DDIT3 rearrangement is a known characteristic of myxoid LPS, its amplification in DDLPS has not been extensively studied. To investigate this, we...
0
1
1
STAT6 Can Be Used in the Diagnosis of Hodgkin Lymphoma; There Are Differences in Expression Among Subtypes
journals.lww.com
the STAT6 (EP325) immunostain, diagnosing Hodgkin lymphoma, its staining frequency, immunolocalization, and its relationship with EBV. Sixty-eight patients representing each Hodgkin lymphoma subtype...
0
2
11
Immunohistochemical Study on Programmed Death Ligand 1 (PD-L1) in Breast Carcinoma and Its Correlation With the Clinicopathological Parameters.
journals.lww.com
in order to maximize its therapeutic role in different clinicopathological settings. This study aimed to evaluate PD-L1 immunohistochemical expression in both tumor cells (TCs) and tumor-infiltrating...
0
2
3
EWSR1::NFATC2 Rearranged Sarcoma.Distinct Clinicopathological Features From a Series of 5 Rare Cases
journals.lww.com
omas with EWSR1–non-ETS fusions, particularly EWSR1::NFATC2 fusion. We identified 5 cases of EWSR1::NFATC2 fusion sarcomas. There was male preponderance and all the patients had a history of trivial...
0
2
2
Check out our Current Issue!! . Figure from "Telomerase Immunocytochemistry in Lymphocytes From Chronic Lymphocytic Leukemia” by Sučić, et al. 🔗 Read the full article here:
1
6
22
Immune Checkpoint Molecule Expression, 9p24.1 Gene Alterations, and Tumor Microenvironment of Primary Central Nervous System Lymphomas and Their Clinical Relevance
journals.lww.com
/refractory cases. This study evaluates the tumor microenvironment (TME), immune checkpoint molecule expression, and the relationship with 9p24.1 gene region alterations in a large cohort of PCNS-L...
0
3
10
Tissue Factor Pathway Inhibitor-2 Expression in Uterine Cervical Clear Cell Carcinoma: A Potential Biomarker for Clinical Diagnosis
journals.lww.com
cal analyses. In this exploratory study, we conducted an immunohistochemical investigation to determine whether TFPI2 is expressed in cervical cancers, especially CCCC. Further, we examined the...
0
2
3
RT @IHC_guy: We’re one day away from David Dabbs’ @ISIMMweb webinar highlighting the HER2 CASI study—our final webinar of the academic year….
us02web.zoom.us
Zoom is the leader in modern enterprise video communications, with an easy, reliable cloud platform for video and audio conferencing, chat, and webinars across mobile, desktop, and room systems. Zoom...
0
7
0
Just published! Check out this latest article by @indulkarshreeya @vishalrao1980. 🔬 Molecular subtyping of bladder cancer is vital—but often out of reach.🧪 IHC markers GATA3, KRT20, KRT14, KRT5 used to stratify UCs.⚠️ Dual-negative had poorest survival (25%), luminal best (80%)
Deciphering the Molecular Landscape of Urothelial Carcinoma: Immunohistochemistry-based Subtyping Using 4 Easily Available Antibodies for Cost-effective Stratification
0
13
31
Deciphering the Molecular Landscape of Urothelial Carcinoma: Immunohistochemistry-based Subtyping Using 4 Easily Available Antibodies for Cost-effective Stratification
journals.lww.com
essible antibodies. Examining 100 UCs from 2020 to 2021, encompassing both chemotherapy-naïve MIBC and NMIBC, acquired through transurethral resection or radical resection, we employed IHC with...
0
2
8
The Expression and Clinical Features of 8 Immunohistochemistry Markers in Adrenal Cortical Adenomas and Pheochromocytomas
journals.lww.com
valuable insights into the diagnosis and management of adrenal tumors. We retrospectively analyzed cases of patients treated in the urology department of our hospital from April 2017 to May 2022,...
0
2
9
Just published! Check out this latest article! .🔵 PD-L1 expression showed high concordance between cores and full slides. 🔵 CD8+ T cell and CD68+ macrophage densities varied; cores underrepresented immune infiltrates. @fabiotavora #IHCpath #lungcancer
Immune Profiling of Incidental NSCLC Patients: Comparison Between Tumor Sections and TMA Cores
0
3
6
Immune Profiling of Incidental NSCLC Patients: Comparison Between Tumor Sections and TMA Cores
journals.lww.com
urvival, overall response rate, and progression-free survival in NSCLC patients. This study aimed to evaluate the concordance of PD-L1 expression in NSCLC patients using tissue microarrays (TMA) as...
0
2
4